Comparing Simulated Patients and Manikin Based Simulation in Obstetrics
Effect of Manikin and Simulated-Patient Realism on Training Experience and Performance in Emergency Team Training: A Mixed-Methods Research Programme: Substudy C - Simulated Patient vs. MamaAnne for PPH and Eclampsia Team Training
The aim of this randomized study is to compare a live, trained simulated patient with a high-fidelity manikin in obstetric emergency team training using two standardized scenarios. The participants in this study are intact clinical teams (e.g., obstetrics, anesthesiology, and nursing/midwifery staff routinely working together in obstetric emergencies) and are recruited as a unit. Each team will either have both scenarios with the live, trained standard patient or the high fidelity manikin. Both scenarios are standardized: One scenario is about post-partum hemorrhage (PPH), a severe bleeding after giving birth, and the other scenario is about eclampsia, an emergency in obstetrics that causes hypertensive crisis and seizures. The order of scenarios is random. After each scenario all team members fill out questionnaires about realism and cognitive stress. After the second debriefing, a focus group of approximately 15 minutes is conducted with each team with a standardized procedure and questions.
Aperçu de l'étude
Statut
Les conditions
Intervention / Traitement
Description détaillée
The focus group is led by a moderator who did not facilitate either debriefing and who holds no supervisory relationship to any participant. A short semi-structured guide of five questions is used. The focus group is a separate element of the study and is not one of the two debriefings; it begins only once the second debriefing has been formally closed.
Type d'étude
Inscription (Estimé)
Phase
- N'est pas applicable
Contacts et emplacements
Coordonnées de l'étude
- Nom: Mathias Maleczek, PD Dr.
- Numéro de téléphone: +4314040041020
- E-mail: mathias.maleczek@meduniwien.ac.at
Sauvegarde des contacts de l'étude
- Nom: Florian Berger, Dr.
- Numéro de téléphone: +4314040041020
- E-mail: florian.berger@meduniwien.ac.at
Lieux d'étude
-
-
State of Vienna
-
Vienna, State of Vienna, L'Autriche, 1090
- Medical University of Vienna
-
Contact:
- Mathias Maleczek, PD Dr.
- Numéro de téléphone: +4314040041020
- E-mail: mathias.maleczek@meduniwien.ac.at
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
Accepte les volontaires sains
Sexes éligibles pour l'étude
La description
Inclusion Criteria:
- Individual inclusion criteria are: physician, midwife, registered nurse, or paramedic; current clinical duties in obstetric or peripartum emergency care
- written informed consent
Exclusion Criteria:
- Pregnancy
- Exclusion criteria are pregnancy and prior participation in a simulation study using the same obstetric scenarios.
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Autre
- Répartition: Randomisé
- Modèle interventionnel: Affectation parallèle
- Masquage: Aucun (étiquette ouverte)
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
|---|---|
|
Comparateur actif: Trained Simulated Patient
Both scenarios portrayed by a trained Simulated Patient (PPH: verbalized pain/distress, simulated blood loss via MamaNatalie; eclampsia: seizure activity, verbal responses where clinically appropriate, hypertensive crisis presentation). |
Trained, standardized patient portraying obstetric woman with MamaNatalie simulator
Autres noms:
|
|
Expérimental: High-fidelity Manikin
Both scenarios portrayed by a high fidelity obstetric manikin (PPH: verbalized pain/distress, simulated blood loss via MamaAnne; eclampsia: seizure activity, verbal responses where clinically appropriate, hypertensive crisis presentation). |
Patient portrayed by high fidelity obstetric manikin MamaAnne |
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
SRS-Score
Délai: Immediately after each scenario (scenario 1 and scenario 2, on the day of training)
|
Perceived realism of the simulation measured with the Simulation Realism Scale (SRS), completed individually by every team member after each of the two scenarios. Score range [min] to [max]; higher scores indicate greater perceived realism. |
Immediately after each scenario (scenario 1 and scenario 2, on the day of training)
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Perceived realism on a Numeric Rating Scale (NRS)
Délai: Immediately after each scenario (scenario 1 and scenario 2, on the day of training)
|
Single-item perceived realism rated on a Numeric Rating Scale (NRS) from 0 (not realistic at all) to 10 (completely realistic); higher scores indicate greater perceived realism. Completed individually by every team member after each scenario. |
Immediately after each scenario (scenario 1 and scenario 2, on the day of training)
|
|
Themes on perceived realism and training experience (reflexive thematic analysis of focus groups)
Délai: Immediately after the debriefing of the second scenario, on the day of training
|
Debriefing and focus group transcripts are analyzed together using reflexive thematic analysis. Two researchers code independently; a codebook is developed after the first four teams and applied to the remainder, with discrepancies resolved in consensus discussion and a third researcher consulted where consensus is not reached. Coders are not blinded to modality, since modality is evident from the transcript; this is reported as a limitation. Analytic adequacy is judged against information power rather than data saturation, taking into account the narrow study aim, the high specificity of the sample, and the use of an established theoretical frame. |
Immediately after the debriefing of the second scenario, on the day of training
|
Collaborateurs et enquêteurs
Parrainer
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude (Estimé)
Achèvement primaire (Estimé)
Achèvement de l'étude (Estimé)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Réel)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Termes MeSH pertinents supplémentaires
- Maladies urogénitales
- Processus pathologiques
- Maladies urogénitales féminines et complications de la grossesse
- Complications du travail obstétrical
- Complications de grossesse
- Hémorragie
- Hypertension induite par la grossesse
- Troubles puerpéraux
- Hémorragie utérine
- Conditions pathologiques, signes et symptômes
- Éclampsie
- Hémorragie post-partum
Autres numéros d'identification d'étude
- Fidelity C
Plan pour les données individuelles des participants (IPD)
Prévoyez-vous de partager les données individuelles des participants (DPI) ?
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Étudie un produit d'appareil réglementé par la FDA américaine
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .